Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors
Clinical trial NCT02691767 · COMPLETED
Trial details
- NCT number
- NCT02691767
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2018-01-16
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.